- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Patent holdings for IPC class C07K 14/315
Total number of patents in this class: 840
10-year publication summary
|
71
|
56
|
84
|
70
|
55
|
53
|
61
|
67
|
57
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oxford University Innovation Limited | 1520 |
23 |
| Novartis AG | 10856 |
20 |
| Affibody AB | 114 |
16 |
| Glaxosmithkline Biologicals S.A. | 1637 |
15 |
| The Regents of the University of California | 19887 |
13 |
| Children's Medical Center Corporation | 1865 |
13 |
| President and Fellows of Harvard College | 5972 |
12 |
| Kaneka Corporation | 4519 |
11 |
| Griffith University | 155 |
10 |
| Intervacc AB | 15 |
10 |
| Minervax ApS | 12 |
9 |
| The Trustees of the University of Pennsylvania | 4317 |
8 |
| St. Jude Children's Research Hospital | 243 |
8 |
| Chr. Hansen A/S | 1059 |
8 |
| International N&h Denmark ApS | 336 |
8 |
| Duke University | 3065 |
7 |
| DuPont Nutrition Biosciences ApS | 477 |
7 |
| Bioatla, Inc. | 106 |
7 |
| Pfizer Inc. | 3374 |
6 |
| Wyeth LLC | 652 |
6 |
| Other owners | 623 |